Pelitrexol

DB12757InvestigationalSmall molecule

Pelitrexol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

Mechanism: Pharmacologically active on Trifunctional purine biosynthetic protein adenosine-3
Curator reviewed
Formula / weight: C₂₀H₂₅N₅O₆S · 463.51 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyQXOPTIPQEVJERB-JQWIXIFHSA-NSMILESCC1=C(CC[C@@H]2CNC3=C(C2)C(=O)NC(N)=N3)SC(=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Pelitrexol, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.